Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis. - Wikidata - awgldk - TriplyDB

Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.

Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.

http://www.wikidata.org/entity/Q39126217

about

Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice.In Silico Analysis and Experimental Validation of Active Compounds from Cichorium intybus L. Ameliorating Liver Injury.IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency.Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Molecular biology of pediatric brain tumors and impact on novel therapies.Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.Epigenomic regulation of oncogenesis by chromatin remodeling.Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.SNF5 as a prognostic factor in skull base chordoma.

P2860

Q21245750-CCDD6B1D-CF1A-4096-8255-69CEA6DEA640 Q26782730-1CF046A6-FAEB-4B59-83D1-FE87CBE9F7B8 Q33820556-8A2685DB-8936-425E-BF4D-5734E01F7D9D Q35781833-942BB422-0646-4FF9-9090-E3DE9788EE84 Q36179660-AAA7A814-2BAC-4B62-B325-143B0A51672B Q36657085-19C3BEC7-5BEA-436F-A578-701EA7CFF7C9 Q37031704-C1CE7532-B085-4ECF-8BAA-21065929BCB9 Q37225222-16A3096A-2EEC-4437-A254-2305632175C4 Q38359284-B86C7CA5-4996-4AB6-9609-80B9DD307478 Q38682244-2DFDD659-2568-4878-8563-1A5A44C513F3 Q38709544-A9881EF8-5663-42DA-B725-F1A75010567D Q38835302-FEAB2608-E81E-4651-AFD1-D239A3F79DC5 Q47925228-F4798305-A58D-4C6C-BE5F-BFFD611727C3

P2860

Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.

http://www.wikidata.org/entity/Q39126217

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.

@en

Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.

@nl

type

label

Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.

@en

Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.

@nl

prefLabel

Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.

@en

Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.

@nl

P1433

Q39126217-E08C9B08-0038-42C8-8454-2A76391716E9

P1476

Q39126217-7D36AF5A-523C-4AD5-A679-4243B5F4CA7E

P2093

Q39126217-27AAE6C4-63F9-4C0A-AC9C-E9750FA0C999

Q39126217-5B7CB42A-0841-4BD0-BFC4-7354A59380D2

Q39126217-83CAD619-AB8C-49F5-B540-FC13A9D07A02

Q39126217-8AF08A6B-48D4-4441-AB0D-D9D49C507E58

P2860

Q39126217-015D8DA1-886C-4D51-B002-72DA5E2B57E4

Q39126217-0C10DCFB-8906-4BB5-955F-EB55FE9D2812

Q39126217-0FF2F385-E571-4E89-955F-FAD1C8B29568

Q39126217-129E90E0-A1E2-40A2-9297-900EE20D3F93

Q39126217-13079566-E80F-49E5-960C-8345616808C0

Q39126217-2788475B-6B88-47B9-9B75-F75C5263B13B

Q39126217-294FE004-B7E8-4E1D-B757-6A9421B0E426

Q39126217-2A66F9CA-13C1-461B-8B6D-84268F1B2E1F

Q39126217-2AA39207-DA8F-4AF7-90D3-A12D1417095E

Q39126217-2CFE431A-1A7D-4C09-B226-D001BE965407

P2888

Q39126217-A27593AB-1C5C-4271-B8D2-0B69C8A9531A

P304

Q39126217-028006F7-FB9B-4FB2-AB0C-EA27F40182A4

P31

Q39126217-D4436A87-FA7E-4D57-BB8E-DA69D822AFB8

P356

Q39126217-6DB4B39B-6AF5-4E86-995A-AD0B4AE75563

P407

Q39126217-FEF474D5-631E-4CA3-84D4-DCEA7C7D3F02

P433

Q39126217-9818DBFC-D398-454C-BFAE-959B66C6D8E4

P478

Q39126217-E6DBC748-35D1-4E4F-B548-3BBE882A3D7B

P577

Q39126217-FC088154-B031-425C-AB1F-D76BD6DCB1F3

P698

Q39126217-2A105186-2E7A-4A2A-8DC8-EDB2D27487F6

P356

P1433

P1476

Loss of IGFBP7 expression and ...... 1/Snf5-mediated tumorigenesis.

@en

P2093

A Eden

http://www.w3.org/2001/XMLSchema#string

A Klochendler

http://www.w3.org/2001/XMLSchema#string

J Darr

http://www.w3.org/2001/XMLSchema#string

S Isaac

http://www.w3.org/2001/XMLSchema#string

P2860

Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

Inhibition of insulin receptor activation by insulin-like growth factor binding proteins

Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm

Apoptotic response of malignant rhabdoid tumor cells

c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function

P2888

P304

3024-3032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2013.261

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23851500

http://www.w3.org/2001/XMLSchema#string